Embolic Protection Devices Market Forecast to 2024 Profiling Abbott, Cardinal Health, Medtronic & More

The latest Global Embolic Protection Devices industry forecast report covers the key technological advancement and market trends to 2024 and further lays out an analysis of the factors influencing the supply/demand for embolic protection devices with the opportunities/challenges faced by industry participants.

The escalating occurrence of cardiovascular diseases, particularly among the geriatric population, thus, is a major driving force for Embolic Protection Devices Market. These components are prominently used in cardiac surgeries to reduce complications due to debris, owing to their superior design. Indeed, these devices also find extensive usage in ventricular assist device explantation and high-risk coronary artery bypass grafting. Driven by the nature of seriousness of these procedures, hospitals mandatorily prefer official FDA-approved EPD devices – a trend that is encouraging embolic protection devices market players to constantly improve their product portfolios.

Get a Sample Copy of this Report @ https://www.marketstudyreport.com/request-a-sample/934011/?utm_source=OPR-CC

An inherent vertical of the healthcare space, the competitive landscape of embolic protection devices market is defined by geographical expansions and M&As. Recently for instance, InspireMD, Inc., one of the global producers of embolic protection devices, signed an agreement with various regional distributors for extending its presence across myriad geographies.

In Greece, the firm partnered with T-Vascular IKE Medical Supplies and in the Caribbean, it has collaborated with SRL and Endo-Serv. With this exclusive distribution agreement, InspireMD is looking forward to attracting more customers for supplying highly advanced and minimally invasive medical devices. Another factor that may support the embolic protection devices industry player in its endeavor is that its regional distributors encompass a loyal, strong consumer base. Indeed, companies have been continually adopting such tactics to sustain in embolic protection devices market, the valuation of which stood at USD 870 million in 2016.

Recently in 2017, the U.S. based Claret Medical received clearance for its Sentinel Cerebral Protection System. With the development of this system, it has set a high standard of care in the United States to protect patient from strokes. Apparently, this system has the capability to remove the debris associated with TAVR (transcatheter aortic heart valve replacement).

As per statistics, the implementation of this novel system in TAVR has protected over 5,500 patients from the risk of stroke. In alignment with Claret, numerous other giants in embolic protection devices industry have been increasingly involved in the development of clinically advanced and next-generation minimally invasive medical devices. This would have considerable influence on product demand over the years ahead.

Apart from product differentiation, considering the future scope of highly advanced EPDs, companies in embolic protection devices industry have also been involved in the clinical trials of medical devices. The major concerns for these firms presently is safety and feasibility associated with the products. Recently, Contego Medical, LLC, a leading producer of medical devices for peripheral vascular and cardiovascular treatments, commenced a clinical trial for one of its drugs. The trial was conducted to evaluate the safety of the Neuroguard IEP® 3-in-1 Carotid Stent & Post-Dilation Balloon System with an Integrated Embolic Protection. With this development, Contego Medical has indeed added value to its neurovascular product portfolio and its research spectrum, encouraging other embolic protection devices industry biggies to do the same.

Prominent industry players include Abbott Laboratories, Cardinal Health, Medtronic, Boston Scientific, Gore Medical, Claret Medical, Allium Medical, Innovative Cardiovascular Solutions, Edward Lifesciences, and Transverse Medical among others. In order to further strengthen its competitive advantage, the market players are investing into research and development of embolic protection devices for expanded clinical applications such as cerebral emboli protection and lower extremities procedures.

Purchase this premium report at: https://www.marketstudyreport.com/securecheckout/paymenta/934011?msfpaycode=sumsf/?utm_source=OPR-CC

Numerous behemoths across embolic protection devices market have been aiming to set up novel benchmarks with regards to innovative product development. For instance, recently in 2017, Venus Medtech received the official approval from the China FDA for its Venus A-valve device. Apparently, this device offers a less invasive treatment solution for patients classified under the high-risk category. Medical device manufacturers thus, have been shifting their focus toward the development of highly advanced EPDs. Aided by their significant efforts, in conjunction with the emerging application arenas of these components, like atherectomy procedures, embolic protection devices industry is likely to garner appreciable gains over 2017-2024.

Related Report:

On a related note, another research has been added by Market Study Report in its database titled Reprocessed Medical Devices Market Size by Product, By End-use Industry Analysis Report, Regional, Application Potential, Competitive Market Share & Forecast, 2017 – 2024.

According to this research, U.S. held substantial revenue share owing to rising prevalence of heart disease, supportive regulatory framework, high number of medical products producers involved in the reprocessing programs. Moreover, encouraging governing policies along with established healthcare infrastructure upsurges reprocessed medical devices market growth during the forecast period. According to, Centers for Disease Control & Prevention (CDC) statistics updated in November 2017, nearly half of Americans have three risk factors of heart disease, these include high cholesterol, smoking, and high blood pressure.

Companies operational in the reprocessed medical devices includes Stryker Sustainability, Vanguard, GE Healthcare, Vascular Solutions, SureTek Medical, Centurion Medical Products, Soma Technology, Hygia Health Services, Steril Med (Ethicon Endo-Surgery), Mediline ReNewal, Midwest Reprocessing Centre, Medtronic, ReNu Medical, Pioneer Medical Devices, Steripro Canada, and Siemens Healthcare.

Read more on this report at: https://www.marketstudyreport.com/reports/reprocessed-medical-devices-market/?utm_source=OPRRR-cc

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report
The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https:/www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/
More Report at:http://reports.algosonline.com/

This release was published on openPR.